Popular on Amzeal
- ProStrategix Proud To Announce Being Chosen as a Top Web Design Agency by DesignRush
- Romance Scams. Senior Women Hit the Hardest - Be Smarter Than Your Phone Cyber Security Podcast
- Black Owned Sneaker Company TRONUS Shakes Up Footwear Industry With Explosive Launch Despite Pandemic
- Trissential Adds New Talent to Leadership Team
- Zuora CEO Headlines Keynote Speakers at Optimal: The AI Conference for Procurement Teams
- Syxsense Announces a Customizable Dashboard Designer to Easily Deliver Useful Information to IT and Security Teams in Real-Time
- Business Owners Can Find System Flaws Before Cyber Criminals Do with the No-Cost Discovery Assessment from Infoaxis
- HLN Releases Open Source Vaccine Provider Agreement System
- BrainKraft and career.pm Announce Product Launch Partnership
- New York State Small Business Owner Molly Bakewell Chamberlin Appointed to Washington, D.C.-Based NSBA Leadership and Technology Councils
Similar on Amzeal
- International HPV Awareness Day Summit
- Aesthetic Mentor Continues National Expansion with New Medical Training Facility in Hartford, Connecticut
- Marketing Powerhouse With Fortune 500 Experience Launches My CMO Fractional CMO Services
- NLX-112 Restores Motor Function in a Transgenic Model of Spinocerebellar Ataxia
- Virtual Healthcare Conference Feb. 24-26 Highlights a Year of Challenges, Solutions
- Covid Conditions Intensify Opioid Overdose Deaths
- Sedia Biosciences Board Announces Changes to Executive Leadership
- Thiel College launches new Bachelor of Science in nursing program
- Galaxy Diagnostics Launches the Most Sensitive Test Available for Direct Detection of Cat Scratch Disease
- 83bar, Inc. announces hiring of key managers and campaign delivery staff
AXT Assists Vaxine in the Search for a COVID-19 Vaccine
Amzeal News/10404999
WARRIEWOOD, Australia - Amzeal -- The COVID-19 pandemic is crippling the world and its full effects will not be felt for many years to come. Researchers have scrambled to characterize the SARS-CoV2 virus so they can help develop a vaccine for this insidious disease. AXT and Vaxine teamed up to help in the fight against COVID-19.
Vaxine has an established track record with developing vaccines, having already developed formulations for seasonal and pandemic influenza, hepatitis B, Japanese encephalitis, West Nile Virus, malaria, rabies, and allergy. They started working on a vaccine for COVID-19 in January 2020, before the World Health Organisation had even declared it a global pandemic.
To assist with their research, AXT loaned Vaxine an Etaluma LumaScope LS620. The LS620 is an extremely compact digital inverted light microscope designed for long-term live-cell imaging and suitable for use in incubators and other enclosures.
When asked about Vaxine's COVID-19 research, Dr. Yoshikazu Honda-Okubo, Senior Research Scientist at Vaxine said, "using modelling approaches Vaxine scientists rapidly confirmed that the COVID-19 spike protein binds the same receptor as SARS CoV, namely the human angiotensin-converting enzyme 2 (ACE2) to gain entry to human's cells making the spike protein the key target antigen for the development of our vaccine, now named COVAX-19® vaccine. COVAX-19® vaccine comprises a recombinant spike protein antigen formulated with Vaxine's proprietary Advax™ adjuvant, which drives a potent T cell and neutralizing antibody response against the target virus. COVAX-19® vaccine has been shown to be highly immunogenic in mice and macaque monkeys, and COVID-19 protection studies are currently underway in the ferret model." He added, "We were able to confirm the expression of the SARS-CoV-2 Spike protein in gene-transfected human cells by immunostaining using a specific antibody. Fluorescent signals were clearly observed as expected by Lumascope."
More on Amzeal News
Richard Trett, Managing Director at AXT commented, "we are pleased that we have been able to contribute, even in a small way to promising Australian research that may pave the way to a vaccine for COVID-19".
The Etaluma Lumascopes are part of AXT's life science portfolio. For details on them and AXT's other solutions for life science research, please visit www.axt.com.au/segments/life-sciences/.
Vaxine has an established track record with developing vaccines, having already developed formulations for seasonal and pandemic influenza, hepatitis B, Japanese encephalitis, West Nile Virus, malaria, rabies, and allergy. They started working on a vaccine for COVID-19 in January 2020, before the World Health Organisation had even declared it a global pandemic.
To assist with their research, AXT loaned Vaxine an Etaluma LumaScope LS620. The LS620 is an extremely compact digital inverted light microscope designed for long-term live-cell imaging and suitable for use in incubators and other enclosures.
When asked about Vaxine's COVID-19 research, Dr. Yoshikazu Honda-Okubo, Senior Research Scientist at Vaxine said, "using modelling approaches Vaxine scientists rapidly confirmed that the COVID-19 spike protein binds the same receptor as SARS CoV, namely the human angiotensin-converting enzyme 2 (ACE2) to gain entry to human's cells making the spike protein the key target antigen for the development of our vaccine, now named COVAX-19® vaccine. COVAX-19® vaccine comprises a recombinant spike protein antigen formulated with Vaxine's proprietary Advax™ adjuvant, which drives a potent T cell and neutralizing antibody response against the target virus. COVAX-19® vaccine has been shown to be highly immunogenic in mice and macaque monkeys, and COVID-19 protection studies are currently underway in the ferret model." He added, "We were able to confirm the expression of the SARS-CoV-2 Spike protein in gene-transfected human cells by immunostaining using a specific antibody. Fluorescent signals were clearly observed as expected by Lumascope."
More on Amzeal News
- Concerned Citizens of South Central Los Angeles Send Open Letter To Biden Administration
- Footprint Project Partners with Clean Energy Leaders to Deploy Solar Energy Storage to Texas for Winter Storm Recovery
- Sandline Global Fortifies World-Class Executive Team: Glenn Hopper Joins as Chief Financial Officer
- RSTOR Enhances Software Defined Cloud Platform to Support Hybrid, Multi-Cloud Enterprise Infrastructures
- GBKSOFT reveals the benefits of Building Websites with PHP in 2021?
Richard Trett, Managing Director at AXT commented, "we are pleased that we have been able to contribute, even in a small way to promising Australian research that may pave the way to a vaccine for COVID-19".
The Etaluma Lumascopes are part of AXT's life science portfolio. For details on them and AXT's other solutions for life science research, please visit www.axt.com.au/segments/life-sciences/.
Source: AXT Pty Ltd
Filed Under: Medical
0 Comments
Latest on Amzeal News
- Recording Artist "Cherne" Crystal Brown auditions for Sony Music, Atlantic Records and Capitol Records and it doesn't stop there
- Technicolor HERO Partners Weigh in on Network Service Provider Trends Established in 2020 and Offer Views on What to Expect in 2021
- Honorary Oscar-Winner Charles Burnett brings his award winning film on COVID-19 / Black Hollywood to the Prestigious Pan African 2021 Film Festival
- VPI Adds a 1RU 24-Port CAT7 Feed-Through Patch Panel
- NTI Introduces a 4K 10.2Gbps HDMI USB KVM Extender via One CAT6/7 Cable or LC Singlemode/Multimode Fi
- In a year of recession, Lantek closes 2020 with record sales figures and customer numbers
- Lifemesh Corp Announces Clinic-as-a-Service General Availability
- Microsoft Names Ovatio Technologies as a Charter Member in Exclusive Content Services Partner Program
- The Koedo Kawagoe Spring Festival Celebrates the Arrival of Springtime in Kawagoe, Japan
- Aaron's Energy: An Unexpected Journey Through Grief and the Afterlife With My Brilliant Son
- Cimcorp Shares Strategies for Building Business Resilience and Future-proofing Warehouse Operations
- Advanced Acoustic Technology Corp. Signs New Yorker Electronics to new Distribution Deal
- MC Residential Activates in the Wake of Texas Weather Crisis
- The Best SEO Company in New York City Is Proving Local Businesses Free SEO Audit As COVID-19 Relief
- Managing Artificial Intelligence (AI) Projects Mini-Conference scheduled for March 27
- Martello iQ Wins Top Marks in TechGenix Product Review
- Savvy Coders Offers New Data Analytics + Python Course
- Infogix Recognized for Data Catalog Solution by Industry Leading Media and Analysts
- Fennemore Names New Office Managing Partners, Practice Group Leaders & Chief Diversity Officer
- Apex Process Consultants announces No Code forms